TargetMol

KNI 122

Product Code:
 
TAR-T32408
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T32408-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T32408-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
KNI 122is a heptapeptide analog.
CAS:
138228-18-9
Molecular Weight:
852.003
Purity:
0.98
SMILES:
CCC(C)C(NC(=O)C1CCCN1C(=O)C(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)C(Cc1ccccc1)NC(=O)C(N)CO)C(=O)NC(C(C)C)C(N)=O

Documents

References

Strutynska NY, Zatovsky IV, Baumer VN, Ogorodnyk IV, Slobodyanik NS. KNi(0.93)Fe(II)(0.07)Fe(III)(PO4)2: a new type of structure for a compound of composition M(I)M(II)M(III)(PO4)2. Acta Crystallogr C Struct Chem. 2014 Feb;70(Pt 2):160-4. doi: 10.1107/S2053229614000679. Epub 2014 Jan 31. PubMed PMID: 24508960. Kiriyama A, Nishiura T, Yamaji H, Takada K. Metabolic characterization of a tripeptide human immunodeficiency virus type 1 protease inhibitor, KNI-272, in rat liver microsomes. Antimicrob Agents Chemother. 1999 Mar;43(3):549-56. PubMed PMID: 10049266; PubMed Central PMCID: PMC89159. Goto T, Nakano T, Kohno T, Morimatsu S, Morita C, Hong W, Kiso Y, Nakai M, Sano K. Targets of a protease inhibitor, KNI-272, in HIV-1-infected cells. J Med Virol. 2001 Mar;63(3):203-9. PubMed PMID: 11170058. Kiriyama A, Nishiura T, Yamaji H, Takada K. Physiologically based pharmacokinetics of KNI-272, a tripeptide HIV-1 protease inhibitor. Biopharm Drug Dispos. 1999 May;20(4):199-205. PubMed PMID: 10440795.